Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, monosodium salt
sodium (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate
Molecular Identity
Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, monosodium salt
sodium (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate
PubChem CID: 76962804
2D Structure
Properties
C43H57N4NaO12
Molecular Formula
844.90
Molecular Weight
g/mol
844.3871
Exact Mass
Da
223
TPSA
May have limited oral absorption
5
H-Bond Donors
15
H-Bond Acceptors
1620
Complexity
SMILES
Canonical SMILES
SMILES: CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)[O-])C=NN5CCN(CC5)C)C.[Na+]Isomeric SMILES
SMILES: C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)[O-])/C=N/N5CCN(CC5)C)/C.[Na+]Synonyms(12)
Rifampicin sodiumRifampicin sodium saltRifampin sodiumSodium rifampinGPE7477YEK38776-75-9Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, monosodium saltRefChem:1098123UNII-GPE7477YEKSCHEMBL30309962RIFAMPICIN SODIUM [WHO-DD]Q27279219
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Molecular Structure
Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, monosodium salt
Loading structure...
Drug Network
Trials and conditions connected to Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, monosodium salt
Loading drug network...